Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 7/28/15 )$65.50
Total Net Assets (As of 6/30/15)$4.99B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 6/30/15)
1 Year40.08%
3 Year39.10%
5 Year31.38%
10 Year15.39%
Morningstar (As of 6/30/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

123 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Data as of 6/30/15. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Amgen Inc 2.91
AbbVie Inc 2.89
Biogen Inc 2.80
Johnson & Johnson 2.64
Allergan plc 2.52
Valeant Pharmaceuticals International Inc 2.49
Sanofi 2.35
Celgene Corp 2.23
Roche Holding AG 2.06
Aetna Inc 1.87
TOTAL24.76

CHARACTERISTICS

Number of Holdings
Equity Issues

95
Market Capitalization
Weighted Average
Median

$60.27B
$30.08B
Portfolio Turnover Ratio
(1-year trailing)

36.80%
Price/Earnings Ratio
(1-year forward)

21.20
Price/Book Ratio
(1-year forward)

7.68
Earnings Growth Rate
(1-year forward)

10.96%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Insys Therapeutics Inc
DBV Technologies SA (ADR)
Alexion Pharmaceuticals Inc
Aetna Inc
Receptos Inc
DETRACTORS
Puma Biotechnology Inc
Valeant Pharmaceuticals International Inc
Mallinckrodt PLC
OvaScience Inc
Ironwood Pharmaceuticals Inc

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 96.72 100.00
 
 
Financials 1.08 -
 
Consumer Staples 0.88 -
 
Energy 0.20 -
 
Cash & Equivalents 1.09 -
 
Restricted Cash 0.03 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 77.99 65.92
Non-U.S. Developed 20.01 34.08
Non-U.S. Emerging 0.88 -
Restricted Cash 0.03 -
Cash & Equivalents 1.09 -

REGIONS (%)

FUNDINDEX
North America 80.57 67.76
Europe 15.74 25.31
Africa/Mideast 1.94 1.12
Asia/Pacific Ex Japan 0.63 1.15
Cash & Equivalents 1.09 -
Restricted Cash 0.03 -

COUNTRIES (%)

FUNDINDEX
United States 77.99 65.91
Switzerland 4.53 9.95
France 3.81 3.10
United Kingdom 3.50 5.35
Canada 2.57 1.84
Israel 1.70 1.12
Denmark 1.48 2.48
Germany 1.17 3.87
Sweden 0.77 0.16
China 0.63 -
Spain 0.37 0.13
South Africa 0.24 -
Netherlands 0.12 -
Cash & Equivalents 1.09 -
Restricted Cash 0.03 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 23.92 51.65
$50 Billion to $100 Billion 16.08 16.55
$10 Billion to $50 Billion 24.34 27.27
$5 Billion to $10 Billion 7.26 3.80
$1 Billion to $5 Billion 22.43 0.73
$500 Million to $1 Billion 2.07 -
$250 Million to $500 Million 0.12 -
N/A 2.66 -

TOP INDUSTRIES (%)

FUNDINDEX
Pharmaceuticals 38.42 54.60
Biotechnology 35.60 15.89
Health Care Equipment 8.06 10.39
Health Care Services 3.88 3.99
Health Care Facilities 3.07 1.20
Health Care Distributors 1.97 2.76
Managed Health Care 1.87 6.25
Health Care Technology 1.67 0.55
Life Sciences Tools & Services 1.19 2.95
Insurance Brokers 1.08 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.